ASND
Ascendis Pharma A/S
NASDAQ · DKHealthcareBiotechnology
$251.76-3.54%
Price as of Jul 20, 2026
ASND profitability
Ascendis Pharma A/S profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 88.2%
- EBITDA margin
- 1.4%
- EBIT margin
- -0.8%
- Net margin
- 58.4%
- Free cash flow margin
- 4.9%
Returns
- Return on equity
- 103.7%
- Return on assets
- 25.3%
- Return on invested capital
- -0.5%
- Asset turnover
- 0.52x
Cash efficiency
- Cash from operations
- $65.9M
- Cash per share
- $11
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.